This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yasuoka, A. Articles by Oka, S. Search for Related Content PubMed PubMed Citation Articles by Yasuoka, A. Articles by Oka, S.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1996, 197-199, Vol 3, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

(1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia

A Yasuoka, N Tachikawa, K Shimada, S Kimura and S Oka
Department of Infectious Diseases, University of Tokyo, Japan. yasuoka@ims.u-tokyo.ac.jp

We detected (1 --> 3) beta-D-glucan (beta-glucan), which is one of the major components of the cyst wall of Pneumocystis carinii, in sera obtained from patients with P. carinii pneumonia (PCP). We confirmed that beta-glucan was detectable by a beta-glucan detection kit (G test; Seikagaku Corporation) in bronchoalveolar lavage fluids (BALFs). The mean concentration of beta-glucan in BALFs obtained from specific- pathogen-free nude mice infected with P. carinii (n = 7; mean, 2,631 [range, 1,031 to 9,095] pg/ml) was significantly higher (P < 0.001) than that in uninfected, specific-pathogen-free mice (n = 7; 6.5 [range, 4.0 to 8.3] pg/ml). The mean level of beta-glucan in BALFs from PCP patients was significantly higher (P < 0.05) than that in BALFs from patients with other lung diseases (7,268 [range, 1,355 to 15,500] pg/ml [n = 4] versus 242.5 [17 to 615] pg/ml [n = 4]). In sera from six of seven patients with PCP, significant levels of beta-glucan (494.1 [8.5 to 1,135] pg/ml) were detected, while it was undetectable in patients with other lung diseases and in a control group. In five patients at follow-up, the level of beta-glucan decreased with clinical improvement. These results suggest that beta-glucan is detectable in sera from patients with PCP and it is a practical serological marker for monitoring of the disease during treatment.

This article has been cited by other articles:

• Marty, F. M., Koo, S., Bryar, J., Baden, L. R. (2007). (1->3){beta}-D-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia. ANN INTERN MED 147: 70-72 [Full Text]  
• Kawayama, T., Fujiki, R., Honda, J., Rikimaru, T., Aizawa, H. (2003). High Concentration of (1->3)-{beta}-D-Glucan in BAL Fluid in Patients With Acute Eosinophilic Pneumonia. Chest 123: 1302-1307 [Abstract] [Full Text]  
• Kottom, T. J., Limper, A. H. (2000). Cell Wall Assembly by Pneumocystis carinii. EVIDENCE FOR A UNIQUE Gsc-1 SUBUNIT MEDIATING beta -1,3-GLUCAN DEPOSITION. J. Biol. Chem. 275: 40628-40634 [Abstract] [Full Text]